Melita Sun Jung
Corporate Officer/Principal chez TERNS PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
Melita Sun Jung is currently the Chief Business Officer at Terns Pharmaceuticals, Inc. She previously held positions as the Senior Director-Corporate Development at Adamas Pharmaceuticals LLC from 2014 to 2017, the Head-Business Development at Sangamo Therapeutics, Inc. from 2017 to 2021, and the Vice President-Business Development at Ascendancy Healthcare, Inc. from 2012 to 2014.
She also served as the Chief Business Officer at Structure Therapeutics, Inc. Ms. Jung completed her undergraduate degree at the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Melita Sun Jung
| Sociétés | Poste | Début |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22/04/2024 |
Anciens postes connus de Melita Sun Jung
| Sociétés | Poste | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2017 |
Ascendancy Healthcare, Inc.
 Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/05/2014 |
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formation de Melita Sun Jung
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Health Technology |
